Company news

Fulgent Genetics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023

February 13, 2023

Fulgent Expands Board of Directors with Addition of Reggie Groves

January 2, 2023

Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference

November 16, 2022

Fulgent Genetics Reports Third Quarter 2022 Financial Results

November 6, 2022

Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company

November 6, 2022

Fulgent Genetics to Participate in Credit Suisse’s 31st Annual Healthcare Conference

October 24, 2022

Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022

October 19, 2022

Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors

August 3, 2022

Fulgent Genetics Reports Second Quarter 2022 Financial Results

August 3, 2022

Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox

August 3, 2022

Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022

July 18, 2022

Fulgent Genetics Reports First Quarter 2022 Financial Results

May 2, 2022

Fulgent Genetics Announces Promotions and Leadership Updates

May 2, 2022

Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California

May 2, 2022

Fulgent Genetics to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022

April 17, 2022

Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results

April 17, 2022

Representatives of Fulgent Genetics to Participate in Oppenheimer’s 32nd Annual Healthcare Conference

March 7, 2022

Fulgent Genetics Announces $250 Million Share Repurchase Program

March 7, 2022

Helio Health Announces Publication of ENCORE Data in Hepatology Communications, Demonstrating Superior Performance of HelioLiver for Early Detection of Liver Cancer

March 6, 2022

EPIC SCIENCES AND FULGENT GENETICS COLLABORATE TO DELIVER DefineMBC™ RESULTS FOR METASTATIC BREAST CANCER PATIENTS

February 23, 2022

Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results

February 22, 2022

Fulgent Genetics Announces Strategic Investment in Spatial Genomics

February 22, 2022

Fulgent Genetics to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday February 23, 2022

February 13, 2022

Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19

November 30, 2021

Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences

November 8, 2021

Fulgent Genetics Reports Third Quarter Financial Results

November 8, 2021

Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection

November 7, 2021

Helio Health and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting® 2021

October 31, 2021

Fulgent Genetics Launches At-Home Neutralizing Antibody Test for COVID-19

October 26, 2021

Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021

October 24, 2021

Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing Program

September 22, 2021

Fulgent Genetics Reports Second Quarter Financial Results

August 8, 2021

Fulgent Genetics Announces Acquisition of CSI Laboratories

August 8, 2021

Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests

August 8, 2021

CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021

July 25, 2021

Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech

May 9, 2021

Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer

May 5, 2021

Fulgent Genetics Reports Record First Quarter Financial Results

May 5, 2021

Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021

April 15, 2021

Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus

March 14, 2021

Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference

March 4, 2021

Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results

March 3, 2021

Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021

February 17, 2021

Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference

January 5, 2021

Fulgent Genetics Extends Partnership with New York City Test and Trace for COVID-19 Testing, Awarded Contract for 2021 School Year

December 28, 2020

PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities

December 16, 2020

Fulgent Genetics to Participate in the Piper Sandler 32nd Annual Healthcare Conference

November 23, 2020

Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million

November 22, 2020

Fulgent Genetics to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference

November 9, 2020

Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million

November 8, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 23 decks. Every deck is listed under its year.